Genetics and molecular biology: Single nucleotide polymorphism associations and their functional significance

Current Opinion in Lipidology

Volumn 17, Issue 3, 2006, Pages 360-362

  Baralle, Marco ^a   Baralle, Francisco E ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; APOLIPOPROTEIN A2; BINDING PROTEIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOXIN; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DNA SEQUENCE; EDITORIAL; ENVIRONMENTAL FACTOR; EXON; FAMILIAL HYPERCHOLESTEROLEMIA; GENE EXPRESSION; GENE MUTATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETICS; HAPLOTYPE; HEART INFARCTION; HUMAN; INTRON; LIPID TRANSPORT; MACROPHAGE; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETICS; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; MOLECULAR BIOLOGY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33646861004     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mol.0000226127.40500.0c     Document Type: Editorial

References (15)

1. Pagani F, Baralle FE. Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 2004; 5:389-396.
2. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002; 3:285-298.
3. Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet 2005; 42:737-748.
4. Pagani F, Raponi M, Baralle FE. Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. Proc Natl Acad Sci USA 2005; 102:6368-6372.
5. Kashima T, Manley JL. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 2003; 34:460-463.
6. Cartegni L, Krainer AR. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 2002; 30:377-384.
7. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921.
8. Garcia-Blanco MA, Baraniak AP, Lasda EL Alternative splicing in disease and therapy. Nat Biotechnol 2004; 22:535-546.
9. Graham CA, Mcllhatton BP, Kirk CW, et al. Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate. Atherosclerosis 2005; 182:331-z340.
10. Graham CA, McClean E, Ward AJ, et al. Mutation screening and genotype : phenotype correlation in familial hypercholesterolaemia. Atherosclerosis 1999; 147:309-316.
11. Garcia CK, Wilund K, Arca M, et at. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 2001; 292:1394-1398.
12. Mango R, Clementi F, Borgiani P, et al. Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet 2003; 40:933-936.
13. Tatsuguchi M, Furutani M, Hinagata J, et al. Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun 2003; 303:247-250.
14. Mango R, Biocca S, del Vecchio F, et al. In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res 2005; 97:152-158.
15. Mercado PA, Ayala YM, Romano M, et al. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Res 2005; 33:6000-6010.